Literature DB >> 31546082

Dexmedetomidine prevents septic myocardial dysfunction in rats via activation of α7nAChR and PI3K/Akt- mediated autophagy.

Tianyi Yu1, Dan Liu1, Min Gao1, Peilang Yang1, Meng Zhang1, Fei Song2, Xiong Zhang3, Yan Liu4.   

Abstract

BACKGROUND AND
PURPOSE: Dexmedetomidine (Dex) has been shown to elicit cardio-protective effects in sepsis. The aim of this study was to investigate the role of autophagy in the protective effects of Dex and its possible mechanism in vivo and vitro. EXPERIMENTAL APPROACH: 6-8-week-old male Wistar rats were performed cecal ligation puncture (CLP) and administered 0.9% saline (CLP group), 50 μg/kg Dex (Dex group), Dex plus chloroquine (20 mg/kg; Dex + CQ group), or 40 μg/kg methyllycaconitin (Dex + MLA group), or 25 μM LY294002 (Dex + LY294002 group). After study, cardiac histology, cardiac function, level of autophagy, cardiomyocytes apoptosis and inflammatory mediators including protein IL-1β, IL-6, and TNF-α were measured. The LPS induced-H9C2 cardiomyocytes were treated with Dex, Dex + CQ and detected for cell apoptosis, autophagy level and cell cycle. KEY
RESULTS: CLP-induced sepsis resulted in cardiac dysfunction, apoptosis, and inflammatory response. Dex exhibited protective effects on the myocardium by the induction of myocardial autophagy and ameliorated the LPS-induced blockade of autophagic flux in H9C2 cells. CQ was found to significantly inhibit Dex-mediated protection of myocardial apoptosis and inflammation. CLP rats treated with Dex in combination with MLA, an antagonist of α7 nicotinic acetylcholine receptor (α7nAChR), exhibited decreased autophagy and increased inflammation and cell death, identifying α7nAchR was involved in the Dex-mediated pathway. In addition, we found that the PI3K/Akt pathway is involved in Dex-mediated autophagy and convergent with α7nAChR-mediated stimulation of autophagy response. CONCLUSIONS AND IMPLICATIONS: For the first time, these data indicate that autophagy is central in Dex-mediated cardio-protection in sepsis. These observations provide the foundation for further study, and may serve as the basis for innovative therapeutic strategies against septic myocardial dysfunction.
Copyright © 2019 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Autophagy; Dexmedetomidine; Heart injury; Sepsis

Mesh:

Substances:

Year:  2019        PMID: 31546082     DOI: 10.1016/j.biopha.2019.109231

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  14 in total

1.  Downregulated HDAC3 or up-regulated microRNA-296-5p alleviates diabetic retinopathy in a mouse model.

Authors:  Songtian Che; Shuai Wu; Peng Yu
Journal:  Regen Ther       Date:  2022-05-18       Impact factor: 3.651

Review 2.  Cardiomyocyte death in sepsis: Mechanisms and regulation (Review).

Authors:  Geping Zhang; Dan Dong; Xianyao Wan; Yongli Zhang
Journal:  Mol Med Rep       Date:  2022-06-15       Impact factor: 3.423

3.  Application and significance of PiCCO monitoring technique combined with troponin I detection in fluid resuscitation of elderly patients with septic myocardial dysfunction.

Authors:  Guojun Pan; Xiuli Fan; Jie Bian; Zemin He; Jiajun Yue; Hua Sun; Fei Zou; Chenglei Chao; Yiqun Chao; Ying Fu; Xiao Wang; Shuhua Chen
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

4.  Dexmedetomidine alleviates cardiomyocyte apoptosis and cardiac dysfunction may be associated with inhibition of RhoA/ROCK pathway in mice with myocardial infarction.

Authors:  Tao Sun; Qian Gong; Ying Wu; Zhiming Shen; Yan Zhang; Shenglin Ge; Jing-Si Duan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-03-29       Impact factor: 3.000

5.  Adiponectin Attenuates Lipopolysaccharide-induced Apoptosis by Regulating the Cx43/PI3K/AKT Pathway.

Authors:  Luqian Liu; Meijuan Yan; Rui Yang; Xuqing Qin; Ling Chen; Li Li; Junqiang Si; Xinzhi Li; Ketao Ma
Journal:  Front Pharmacol       Date:  2021-05-18       Impact factor: 5.810

6.  Dexmedetomidine Attenuates Ischemia/Reperfusion-Induced Myocardial Inflammation and Apoptosis Through Inhibiting Endoplasmic Reticulum Stress Signaling.

Authors:  Yu-Fan Yang; Hui Wang; Nan Song; Ya-Hui Jiang; Jun Zhang; Xiao-Wen Meng; Xiao-Mei Feng; Hong Liu; Ke Peng; Fu-Hai Ji
Journal:  J Inflamm Res       Date:  2021-03-31

7.  Cartilage endplate stem cells inhibit intervertebral disc degeneration by releasing exosomes to nucleus pulposus cells to activate Akt/autophagy.

Authors:  Liwen Luo; Xiuying Jian; Hui Sun; Jinghao Qin; Yanqiu Wang; Ji Zhang; Zigang Shen; Di Yang; Changqing Li; Ping Zhao; MingHan Liu; Zhiqiang Tian; Yue Zhou
Journal:  Stem Cells       Date:  2021-01-18       Impact factor: 6.277

Review 8.  Recent Advances in the Clinical Value and Potential of Dexmedetomidine.

Authors:  Xiaotian Liu; Yueqin Li; Li Kang; Qian Wang
Journal:  J Inflamm Res       Date:  2021-12-30

9.  Protective Effects of Dexmedetomidine on Sepsis-Induced Vascular Leakage by Alleviating Ferroptosis via Regulating Metabolic Reprogramming.

Authors:  Han She; Yi Hu; Yuanqun Zhou; Lei Tan; Yu Zhu; Chunhua Ma; Yue Wu; Wei Chen; Li Wang; Zisen Zhang; Li Wang; Liangming Liu; Tao Li
Journal:  J Inflamm Res       Date:  2021-12-10

10.  Exercise Preconditioning Plays a Protective Role in Exhaustive Rats by Activating the PI3K-Akt Signaling Pathway.

Authors:  Jingjing Li; Peng Xu; Yang Wang; Zheng Ping; Xuebin Cao; Yu Zheng
Journal:  Evid Based Complement Alternat Med       Date:  2020-01-21       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.